R1首席执行官Joe Flanagan对这次合作表示热情，强调实验室有潜力加快医疗服务提供者的投资，创建一个有利于提供者和患者的新型收入周期。Palantir Technologies首席执行官Alex Karp也表达了类似观点，强调了扩展智能自动化以实现更好患者护理的目标。

R1 and Palantir Technologies Inc (NASDAQ: PLTR) have partnered to create R37, an AI lab aimed at revolutionizing healthcare ...

R37 will drive comprehensive automation in revenue cycle operations, reengineering labor-intensive processes such as coding, billing, and denials management to significantly improve efficiency ...

Administrative costs currently make up more than 40% of U.S. hospital expenses, with over $160 billion spent on Revenue Cycle ...

The NIH MERIT (R37) is a prestigious award designed to provide stable, long-term funding support to outstanding, experienced investigators whose productivity is distinctly superior and who are deemed ...

R1, an industry leader in revenue cycle management ("RCM") with over 20 years of experience, and Palantir Technologies (NASDAQ:PLTR), a leader in artificial intelligence systems, have partnered to ...

GOLD Fields said on Monday it had bid A$3.3bn (about R37.7bn) to consolidate its holding in 350,000 ounce a year Australian gold mine Gruyere. This is in terms of a A$3.05 per share offer for ASX ...

Former SA Rugby CEO Jurie Roux has been ordered to pay back Stellenbosch University R37 million, plus interest, in his ...